Birken AG: Clinical Trials

6 trials sponsored by Birken AG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 33Completed 3

Follow Birken AG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12)
Oleogel-S10, non-adhesive wound dressing, Non-adhesive wound dressing only - Wounds
Phase 3CompletedBirken AG1122013-03-012018-07-19
Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds
Oleogel-S10 ointment, Octenilin® wound gel - Burns
Phase 3CompletedBirken AG612012-08-012015-09-28
Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12)
Oleogel-S10, non-adhesive wound dressing, Non-adhesive wound dressing only - Wounds
Phase 3CompletedBirken AG1072012-08-012018-01-23
Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)
Oleogel-S10, Mepilex® soft silicone faced polyurethane foam dressing - Inherited Epidermolysis Bullosa
Phase 2CompletedBirken AG102010-11-012018-01-23
Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites
Oleogel-S10, Moist wound healing dressings alone (Mepilex) on the other half of the skin graft donor site - Accelerating the Epithelialization of Split Thickness Skin Graft
Phase 2CompletedBirken AG242010-04-012015-04-03
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
Oleogel-S10 100 mg/g, Placebo (petroleum jelly) - Actinic Keratoses
Phase 2CompletedBirken AG1652008-10-012015-09-14

Conditions studied

Wounds and Injuries (2)  ·  Burns (1)  ·  Epidermolysis Bullosa (1)  ·  Keratosis, Actinic (1)

Interventions

episalvan (2)  ·  Petrolatum (1)  ·  Transdermal Patch (1)

Countries

Germany (5)  ·  Greece (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)  ·  Latvia (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Agnes Schwieger-Briel, MD (1)  ·  Bernd Hartmann, Dr. (1)  ·  Claus Garbe, Prof. Dr. (1)  ·  Hans Robert Metelmann, Prof (1)  ·  Hans Robert Metelmann, Prof. Dr. med. (1)  ·  Juan Pedro Barret Nerin, MD (1)

Results publications

PMID 25034442, PMID 25124939, PMID 28400148